Foothills Medical Centre

Calgary, Alberta T2W 1S7

8 studies enrolling now · 75 studies all time

What they study most

Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Kidney Injury, Acute Myocardial Infarction, Acute Respiratory Distress Syndrome, Advanced Refractory Left Ventricular Heart Failure, Anemia, Aortic Insufficiency, Aortic Stenosis, Apnea Neonatal, Atherosclerosis, Atrial Fibrillation

Studies at this site

• LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) — Recruiting now
• Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial — Recruiting now
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) — Recruiting now
• Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates — Recruiting now
• AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia — Recruiting now
• Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs — Recruiting now
• PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism — Recruiting now
• Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) — Running, not enrolling
• PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2 — Completed
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• Aveir DR i2i Study — Completed
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• Confirm Rx Insertable Cardiac Monitor SMART Registry — Completed
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease — Completed
• SyncAV Post-Market Trial — Running, not enrolling
• Comparison of Two Pulmonary Embolism Treatments — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) — Completed
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure — Completed
• International Subarachnoid Aneurysm Trial II — Running, not enrolling
• Myocardial Ischemia and Transfusion — Completed
• Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) — Completed
• Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure — Completed
• Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS — Completed
• A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI) — Completed
• Heparin Anticoagulation in Septic Shock — Stopped early
• XIENCE 28 USA Study — Completed
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early
• The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury — Status unconfirmed
• Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients — Completed
• The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) — Completed
• Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza — Completed
• Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
• Clinical Priority Program-Bone Infection Registry — Completed
• Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 — Stopped early
• Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD — Completed
• Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer — Status unconfirmed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed